Enhancing vector bioprocess scalability 2022

Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Cell & Gene Therapy Insights 2022; 8(1), 89–95


Published: 22 February 2022
Ilaria Scarfone, Mike Brewer


Ilaria Scarfone (left), Field Application Specialist, Pharma Analytics, Thermo Fisher Scientific speaks to Mike Brewer, Director and Global Principal Consultant, BioProduction Division, Thermo Fisher Scientific